medigraphic.com
Instituto Nacional de Salud Pública

2009, Number 4

<< Back Next >>

salud publica mex 2009; 51 (4)

Analysis of the mortality due to diarrhea in younger children, before and after the introduction of rotavirus vaccine

Esparza-Aguilar M, Bautista-Márquez A, González-Andrade MC, Richardson-López-Collada VL

Language: Spanish
References: 36
Page: 285-290
PDF size: 130.93 Kb.


ABSTRACT

Objective. To analyze the mortality due to acute diarrhea in children younger than five years old, before and after the introduction of rotavirus vaccine in Mexico. Material and Methods. Number of deaths and mortality rates due to acute diarrhea were compared by children’s age and states’ vaccine status using annual percentage differences before (2000-2005) and after (2006-2007) the introduction of the HRV. Results. From 2000-2007, deaths due to acute diarrhea in children under five years of age dropped 42%. In those states that received the HRV early in 2006, diarrhea mortality decreased between 2006-2007 15.8% in children younger than one year old and 22.7% in children 1-4 years old. Discussion. The observed reduction in mortality due to acute diarrhea in children under five years of age after 2005 can be, in part, attributed to the HRV.


REFERENCES

  1. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect 2003;9:247-262.

  2. Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 2004;6;22(Suppl 1):S49-S54.

  3. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-306.

  4. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008;21:198-208.

  5. Jose MV, Bishop RF. Scaling properties and symmetrical patterns in the epidemiology of rotavirus infection. Philos Trans R Soc Lond B Biol Sci 2003;358:1625-1641.

  6. Pan American Health Organization, World Health Organization, Albert B Sabin Vaccine Institute, Centers for Disease Control and Prevention. Proceedings of the sixth annual international rotavirus symposium, Mexico City July 2004. Washington DC: The Albert B Sabin Vaccine Institute, 2005:43.

  7. Villa S, Guiscafre H, Martinez H, Muñoz O, Gutierrez G. Seasonal diarrhoeal mortality among Mexican children. Bull World Health Organ 1999;77:375-380.

  8. Barron-Romero BL, Barreda-Gonzalez J, Doval-Ugalde R, Zermeño-Eguia Liz J, Huerta-Peña M. Asymptomatic rotavirus infections in day care centers. J Clin Microbiol 1985;22:116-118.

  9. Padilla-Noriega L, Mendez-Toss M, Menchaca G, Contreras JF, Romero-Guido P, Puerto FI, et al. Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico. J Clin Microbiol 1998;36:1688-1692.

  10. Mota-Hernandez F, Calva JJ, Gutierrez-Camacho C, Villa-Contreras S, Arias CF, Padilla-Noriega L, et al. Rotavirus diarrhea severity is related to the VP4 type in Mexican children. J Clin Microbiol 2003;41:3158-3162.

  11. Polanco-Marin G, Gonzalez-Losa M del R, Rodriguez-Angulo E, Manzano-Cabrera L, Camara-Mejía J, Puerto-Solis M. Clinical manifestations of the rotavirus infection and his relation with the electropherotypes and serotypes detected during 1998 and 1999 in Merida, Yucatan, Mexico. J Clin Virol 2003;27:242-246.

  12. Padilla-Noriega L, Arias CF, Lopez S, Puerto F, Snodgrass DR, Taniguchi K, et al. Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol 1990;28:1114-1119.

  13. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-1028.

  14. Laird AR, Ibarra V, Ruiz-Palacios G, Guerrero ML, Glass RI, Gentsch JR. Unexpected detection of animal VP7 genes among common rotavirus strains isolated from children in Mexico. J Clin Microbiol 2003;41: 4400-4403.

  15. Gonzales-Loza MR, Polanco-Marín GG, Puerto-Solis M. Identificação de rotavirus associado ao sorotipo G2 em Yucatan, México. Rev Soc Bras Med Trop 2000;33:553-557.

  16. Rodríguez-Castillo A, Villa AV, Ramirez-Gonzalez JE, Mayen-Pimentel E, Melo-Munguia M, Diaz-Jesus B, et al. VP4 and VP7 genotyping by reverse transcription-PCR of human rotavirus in mexican children with acute diarrhea. J Clin Microbiol 2000;38:3876-3878.

  17. Flisser A, Velasco-Villa A, Martinez-Campos C, Gonzalez-Dominguez F, Briseño-Garcia B, Garcia-Suarez R, et al. Infectious diseases in Mexico. A survey from 1995-2000. Arch Med Res 2002;33:343-350.

  18. Braine T. Rotavirus vaccine introduction in Mexico sets precedent. Bull World Health Organ 2005;83:167.

  19. Secretaría de Salud. Comunicado de prensa 074, a partir de mayo se aplicará vacuna contra rotavirus a todos los menores de seis meses [Monografía Internet]. México DF: Secretaría de Salud, 2007 [consultado 2008 Sep 14]:1. Disponible en: http://portal.salud.gob.mx/redirector?tipo=0&n_seccion=Boletines&seccion=2007-03-07.

  20. GlaxoSmithKline. RotarixTM [Monografía en Internet]. International data sheet version 3.1. [Lugar desconocido]: GlaxoSmithKline, 2004, [consultado el 14 de septiembre de 2008]. 6. Disponible en http://www.eddcontrol.org/files/Rotarix_LA_Data_Sheet_GSK.pdf.

  21. Linhares AC, Ruiz-Palacios GM, Guerrero ML, Salinas B, Perez-Schael I, Clemens SA, et al. A short report on highlights of world-wide development of RIX4414: a Latin American experience. Vaccine 2006;24:3784-3785.

  22. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.

  23. Araujo EC, Clemens SA, Oliveira CS, Justino MC, Rubio P, Gabbay YB, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) 2007;83:217-224.

  24. Ruiz-Palacios GM, Guerrero ML, Bautista-Marquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-Gonzalez L, et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics 2007;120:e253-e261.

  25. Instituto Nacional de Estadística, Geografía e Informática, Secretaría de Salud. Cubo de Defunciones [Base de datos en Internet]. México: Secretaría de Salud, Sistema Nacional de Información en Salud. [consultado en julio 2008]. Disponible en: http://dgis.salud.gob.mx/cubos/.

  26. Secretaría de Salud. Cubo Sistema Estadístico Epidemiológico de las Defunciones [Base de datos en Internet] México: Secretaría de Salud, Sistema Nacional de Información en Salud. [consultado el 30 de julio de 2008]. Disponible en: http://dgis.salud.gob.mx/cubos/.

  27. Consejo Nacional de Población. Proyecciones de la población de México 1970-2030 [Base de datos en Internet]. México DF: Secretaría de Salud: c2004 [consultado el 25 de agosto de 2008]. Disponible en http://dgis.salud.gob.mx/cubos/.

  28. Feachem RG. Interventions for the control of diarrhoeal diseases among young children: promotion of personal and domestic hygiene. Bull World Health Organ 1984;62:467-476.

  29. Mojarro O, Oyarzábal H, Hernández D. Epidemiologia de la infeccion intestinal y estrategia operativa de rehidratacion en el Instituto Mexicano del Seguro Social. Bol Oficina Sanit Panam 1994;116:37-46.

  30. Huttly SR, Morris SS, Pisani V. Prevention of diarrhoea in young children in developing countries. Bull World Health Organ 1997;75:163-174.

  31. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000;78:1246-1255.

  32. Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis 2003;3:275-281.

  33. Sepulveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Olaiz G, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006;368:2017-2027.

  34. Nelson EA, Bresee JS, Parashar UD, Widdowson MA, Glass RI. Asian Rotavirus Surveillance Network. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. Vaccine 2008;26:3192-3196.

  35. Turcios RM, Curns AT, Holman RC, Pandya-Smith I, LaMonte A, Bresee JS, et al. National Respiratory and Enteric Virus Surveillance System Collaborating Laboratories. Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr Infect Dis J 2006;25:451-454.

  36. Kane EM, Turcios RM, Arvay ML, Garcia S, Bresee JS, Glass RI. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica 2004;16:371-377.




2020     |     www.medigraphic.com